Illumina Body Map 2: averaged replicates
Name | miRBASE accession |
---|---|
hsa-miR-29a-3p
|
MIMAT0000086 |
hsa-miR-29b-3p
|
MIMAT0000100 |
hsa-miR-29c-3p
|
MIMAT0000681 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_189839046 | 5.16 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr17_-_48278983 | 4.94 |
ENST00000225964.5
|
COL1A1
|
collagen, type I, alpha 1 |
chr7_+_94023873 | 4.46 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr16_+_55512742 | 3.99 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr19_+_48216600 | 3.88 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
chr8_+_19796381 | 3.79 |
ENST00000524029.1
ENST00000522701.1 ENST00000311322.8 |
LPL
|
lipoprotein lipase |
chr9_+_137533615 | 3.73 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
chr2_-_1748214 | 3.73 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr10_-_103599591 | 3.62 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
chr5_-_122372354 | 3.59 |
ENST00000306442.4
|
PPIC
|
peptidylprolyl isomerase C (cyclophilin C) |
chr9_+_101705893 | 3.49 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr13_+_110959598 | 3.38 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr15_-_48937982 | 3.34 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
chr2_-_238323007 | 3.31 |
ENST00000295550.4
|
COL6A3
|
collagen, type VI, alpha 3 |
chr7_+_116139424 | 3.13 |
ENST00000222693.4
|
CAV2
|
caveolin 2 |
chr17_-_40575535 | 3.11 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
chr21_-_28338732 | 2.98 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr8_-_23261589 | 2.90 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr11_-_86666427 | 2.84 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr5_-_121413974 | 2.70 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr1_+_203444887 | 2.65 |
ENST00000343110.2
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein |
chr19_-_10121144 | 2.61 |
ENST00000264828.3
|
COL5A3
|
collagen, type V, alpha 3 |
chr5_-_141704566 | 2.57 |
ENST00000344120.4
ENST00000434127.2 |
SPRY4
|
sprouty homolog 4 (Drosophila) |
chr1_-_17304771 | 2.54 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr3_-_64673289 | 2.53 |
ENST00000295903.4
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
chr15_+_73976545 | 2.51 |
ENST00000318443.5
ENST00000537340.2 ENST00000318424.5 |
CD276
|
CD276 molecule |
chr12_-_102874416 | 2.49 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr1_+_182992545 | 2.48 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chr1_-_68299130 | 2.41 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr4_+_124320665 | 2.38 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr3_-_120170052 | 2.38 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
chr15_-_79103757 | 2.36 |
ENST00000388820.4
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
chr1_+_185703513 | 2.35 |
ENST00000271588.4
ENST00000367492.2 |
HMCN1
|
hemicentin 1 |
chr9_-_14314066 | 2.27 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr2_-_190044480 | 2.25 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr1_-_26394114 | 2.22 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
chr8_+_75736761 | 2.21 |
ENST00000260113.2
|
PI15
|
peptidase inhibitor 15 |
chr7_+_73442102 | 2.14 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
chr12_+_20522179 | 2.14 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr15_-_68724490 | 2.13 |
ENST00000315757.7
ENST00000423218.2 |
ITGA11
|
integrin, alpha 11 |
chr2_-_119605253 | 2.13 |
ENST00000295206.6
|
EN1
|
engrailed homeobox 1 |
chr16_+_57406368 | 2.12 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr13_-_110959478 | 2.12 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr2_+_56411131 | 2.08 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
chr4_-_142053952 | 2.07 |
ENST00000515673.2
|
RNF150
|
ring finger protein 150 |
chr19_+_709101 | 2.06 |
ENST00000338448.5
|
PALM
|
paralemmin |
chr11_+_75273101 | 2.06 |
ENST00000533603.1
ENST00000358171.3 ENST00000526242.1 |
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
chr16_-_10674528 | 2.03 |
ENST00000359543.3
|
EMP2
|
epithelial membrane protein 2 |
chr7_+_3340989 | 2.02 |
ENST00000404826.2
ENST00000389531.3 |
SDK1
|
sidekick cell adhesion molecule 1 |
chr1_+_110009215 | 2.00 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr4_+_166794383 | 1.99 |
ENST00000061240.2
ENST00000507499.1 |
TLL1
|
tolloid-like 1 |
chr7_+_130126012 | 1.93 |
ENST00000341441.5
|
MEST
|
mesoderm specific transcript |
chr1_+_236849754 | 1.90 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
chr15_-_76005170 | 1.83 |
ENST00000308508.5
|
CSPG4
|
chondroitin sulfate proteoglycan 4 |
chr5_-_146833485 | 1.82 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr3_-_79068594 | 1.82 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr8_-_81787006 | 1.82 |
ENST00000327835.3
|
ZNF704
|
zinc finger protein 704 |
chr17_+_4487294 | 1.79 |
ENST00000338859.4
|
SMTNL2
|
smoothelin-like 2 |
chr8_-_23712312 | 1.78 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr9_+_124413873 | 1.71 |
ENST00000408936.3
|
DAB2IP
|
DAB2 interacting protein |
chr5_-_149535421 | 1.70 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr3_+_99357319 | 1.68 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
chr2_+_159825143 | 1.66 |
ENST00000454300.1
ENST00000263635.6 |
TANC1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chr9_+_107526443 | 1.63 |
ENST00000374762.3
|
NIPSNAP3B
|
nipsnap homolog 3B (C. elegans) |
chr3_-_64211112 | 1.62 |
ENST00000295902.6
|
PRICKLE2
|
prickle homolog 2 (Drosophila) |
chr1_-_40105617 | 1.61 |
ENST00000372852.3
|
HEYL
|
hes-related family bHLH transcription factor with YRPW motif-like |
chr15_-_71055878 | 1.59 |
ENST00000322954.6
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr3_+_130279178 | 1.59 |
ENST00000358511.6
ENST00000453409.2 |
COL6A6
|
collagen, type VI, alpha 6 |
chr15_-_23932437 | 1.58 |
ENST00000331837.4
|
NDN
|
necdin, melanoma antigen (MAGE) family member |
chr2_-_190927447 | 1.58 |
ENST00000260950.4
|
MSTN
|
myostatin |
chrX_+_73641286 | 1.56 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr1_-_225840747 | 1.50 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr1_+_61547894 | 1.50 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr5_-_178772424 | 1.47 |
ENST00000251582.7
ENST00000274609.5 |
ADAMTS2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
chr8_-_122653630 | 1.46 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr19_+_46800289 | 1.45 |
ENST00000377670.4
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit |
chr8_-_93115445 | 1.44 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_+_178062855 | 1.43 |
ENST00000448150.3
|
RASAL2
|
RAS protein activator like 2 |
chr2_-_230933709 | 1.42 |
ENST00000436869.1
ENST00000295190.4 |
SLC16A14
|
solute carrier family 16, member 14 |
chr1_+_201617450 | 1.40 |
ENST00000295624.6
ENST00000367297.4 ENST00000367300.3 |
NAV1
|
neuron navigator 1 |
chr16_+_69221028 | 1.36 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr20_+_55204351 | 1.33 |
ENST00000201031.2
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
chr3_+_126707437 | 1.33 |
ENST00000393409.2
ENST00000251772.4 |
PLXNA1
|
plexin A1 |
chr9_-_110251836 | 1.32 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr12_+_60083118 | 1.31 |
ENST00000261187.4
ENST00000543448.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr16_-_77468945 | 1.30 |
ENST00000282849.5
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18 |
chr19_+_13135386 | 1.29 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr3_+_42695176 | 1.28 |
ENST00000232974.6
ENST00000457842.3 |
ZBTB47
|
zinc finger and BTB domain containing 47 |
chr17_+_21279509 | 1.28 |
ENST00000583088.1
|
KCNJ12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr4_-_100575781 | 1.27 |
ENST00000511828.1
|
RP11-766F14.2
|
Protein LOC285556 |
chr3_+_72937182 | 1.26 |
ENST00000389617.4
|
GXYLT2
|
glucoside xylosyltransferase 2 |
chr19_+_19649057 | 1.25 |
ENST00000586018.1
ENST00000291495.5 |
CILP2
|
cartilage intermediate layer protein 2 |
chr10_-_113943447 | 1.24 |
ENST00000369425.1
ENST00000348367.4 ENST00000423155.1 |
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial |
chr19_-_46272106 | 1.24 |
ENST00000560168.1
|
SIX5
|
SIX homeobox 5 |
chr1_-_46598284 | 1.24 |
ENST00000423209.1
ENST00000262741.5 |
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr10_-_128077024 | 1.20 |
ENST00000368679.4
ENST00000368676.4 ENST00000448723.1 |
ADAM12
|
ADAM metallopeptidase domain 12 |
chr9_+_116917807 | 1.20 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chrX_-_50557014 | 1.16 |
ENST00000376020.2
|
SHROOM4
|
shroom family member 4 |
chr11_+_842808 | 1.16 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr7_+_31092076 | 1.15 |
ENST00000304166.4
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
chr12_-_10875831 | 1.15 |
ENST00000279550.7
ENST00000228251.4 |
YBX3
|
Y box binding protein 3 |
chr8_-_33424636 | 1.14 |
ENST00000256257.1
|
RNF122
|
ring finger protein 122 |
chr2_-_227664474 | 1.14 |
ENST00000305123.5
|
IRS1
|
insulin receptor substrate 1 |
chr9_-_130639997 | 1.14 |
ENST00000373176.1
|
AK1
|
adenylate kinase 1 |
chr8_+_86351056 | 1.12 |
ENST00000285381.2
|
CA3
|
carbonic anhydrase III, muscle specific |
chr14_-_90085458 | 1.10 |
ENST00000345097.4
ENST00000555855.1 ENST00000555353.1 |
FOXN3
|
forkhead box N3 |
chr6_+_43737939 | 1.10 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
chr5_+_140560980 | 1.09 |
ENST00000361016.2
|
PCDHB16
|
protocadherin beta 16 |
chr10_-_30024716 | 1.09 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
chr20_+_30193083 | 1.07 |
ENST00000376112.3
ENST00000376105.3 |
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
chr9_-_113342160 | 1.04 |
ENST00000401783.2
ENST00000374461.1 |
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr16_+_4364762 | 1.03 |
ENST00000262366.3
|
GLIS2
|
GLIS family zinc finger 2 |
chr9_+_35161998 | 1.01 |
ENST00000396787.1
ENST00000378495.3 ENST00000378496.4 |
UNC13B
|
unc-13 homolog B (C. elegans) |
chr13_+_109248500 | 1.00 |
ENST00000356711.2
|
MYO16
|
myosin XVI |
chr8_+_75896731 | 1.00 |
ENST00000262207.4
|
CRISPLD1
|
cysteine-rich secretory protein LCCL domain containing 1 |
chr12_+_13349650 | 0.99 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1
|
epithelial membrane protein 1 |
chr22_-_36236265 | 0.99 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr1_-_236228403 | 0.99 |
ENST00000366595.3
|
NID1
|
nidogen 1 |
chr6_+_53883708 | 0.98 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
chr10_+_120789223 | 0.98 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
chr20_+_42295745 | 0.97 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr8_-_89339705 | 0.95 |
ENST00000286614.6
|
MMP16
|
matrix metallopeptidase 16 (membrane-inserted) |
chr9_-_14910990 | 0.95 |
ENST00000380881.4
ENST00000422223.2 |
FREM1
|
FRAS1 related extracellular matrix 1 |
chr4_-_80994210 | 0.94 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
chr11_-_101454658 | 0.94 |
ENST00000344327.3
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6 |
chr12_+_3186521 | 0.94 |
ENST00000537971.1
ENST00000011898.5 |
TSPAN9
|
tetraspanin 9 |
chr14_+_55034599 | 0.94 |
ENST00000392067.3
ENST00000357634.3 |
SAMD4A
|
sterile alpha motif domain containing 4A |
chr16_+_88493879 | 0.94 |
ENST00000565624.1
ENST00000437464.1 |
ZNF469
|
zinc finger protein 469 |
chr6_-_105585022 | 0.91 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
chr10_-_33246722 | 0.90 |
ENST00000437302.1
ENST00000396033.2 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chr17_-_56032684 | 0.90 |
ENST00000577830.1
|
CUEDC1
|
CUE domain containing 1 |
chr4_-_110223799 | 0.89 |
ENST00000399132.1
ENST00000399126.1 ENST00000505591.1 |
COL25A1
|
collagen, type XXV, alpha 1 |
chr14_+_96671016 | 0.88 |
ENST00000542454.2
ENST00000554311.1 ENST00000306005.3 ENST00000539359.1 ENST00000553811.1 |
BDKRB2
RP11-404P21.8
|
bradykinin receptor B2 Uncharacterized protein |
chr17_-_8055747 | 0.87 |
ENST00000317276.4
ENST00000581703.1 |
PER1
|
period circadian clock 1 |
chr17_-_15165854 | 0.87 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
chr10_-_735553 | 0.87 |
ENST00000280886.6
ENST00000423550.1 |
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr1_+_162351503 | 0.87 |
ENST00000458626.2
|
C1orf226
|
chromosome 1 open reading frame 226 |
chr3_+_191046810 | 0.87 |
ENST00000392455.3
ENST00000392456.3 |
CCDC50
|
coiled-coil domain containing 50 |
chr12_+_56915713 | 0.86 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr12_+_54332535 | 0.84 |
ENST00000243056.3
|
HOXC13
|
homeobox C13 |
chr4_-_157892498 | 0.82 |
ENST00000502773.1
|
PDGFC
|
platelet derived growth factor C |
chr1_-_32169920 | 0.82 |
ENST00000373672.3
ENST00000373668.3 |
COL16A1
|
collagen, type XVI, alpha 1 |
chr3_-_57199397 | 0.81 |
ENST00000296318.7
|
IL17RD
|
interleukin 17 receptor D |
chr1_-_3447967 | 0.81 |
ENST00000294599.4
|
MEGF6
|
multiple EGF-like-domains 6 |
chrX_-_107681633 | 0.81 |
ENST00000394872.2
ENST00000334504.7 |
COL4A6
|
collagen, type IV, alpha 6 |
chr5_-_171881491 | 0.79 |
ENST00000311601.5
|
SH3PXD2B
|
SH3 and PX domains 2B |
chr20_+_34700333 | 0.78 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr7_-_95225768 | 0.78 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
chr7_-_76039000 | 0.78 |
ENST00000275560.3
|
SRCRB4D
|
scavenger receptor cysteine rich domain containing, group B (4 domains) |
chr17_+_27920486 | 0.77 |
ENST00000394859.3
|
ANKRD13B
|
ankyrin repeat domain 13B |
chr9_+_112810878 | 0.77 |
ENST00000434623.2
ENST00000374525.1 |
AKAP2
|
A kinase (PRKA) anchor protein 2 |
chr5_+_149887672 | 0.76 |
ENST00000261797.6
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr2_-_208634287 | 0.75 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
chr7_-_128001658 | 0.74 |
ENST00000489835.2
ENST00000464607.1 ENST00000489517.1 ENST00000446477.2 ENST00000535159.1 ENST00000435512.1 ENST00000495931.1 |
PRRT4
|
proline-rich transmembrane protein 4 |
chr16_+_68298405 | 0.74 |
ENST00000219343.6
ENST00000566834.1 ENST00000566454.1 |
SLC7A6
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
chr3_+_119013185 | 0.73 |
ENST00000264245.4
|
ARHGAP31
|
Rho GTPase activating protein 31 |
chr3_-_48632593 | 0.73 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
chr22_+_42470244 | 0.72 |
ENST00000321753.3
|
FAM109B
|
family with sequence similarity 109, member B |
chr4_+_113066552 | 0.71 |
ENST00000309733.5
|
C4orf32
|
chromosome 4 open reading frame 32 |
chr3_+_159557637 | 0.71 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr9_-_112083229 | 0.71 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
chr6_+_125283566 | 0.70 |
ENST00000521654.2
|
RNF217
|
ring finger protein 217 |
chr4_+_183164574 | 0.69 |
ENST00000511685.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr9_+_112542572 | 0.68 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
chr1_+_203595903 | 0.68 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr15_+_42867857 | 0.68 |
ENST00000290607.7
|
STARD9
|
StAR-related lipid transfer (START) domain containing 9 |
chr22_-_39640756 | 0.67 |
ENST00000331163.6
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr3_+_182971018 | 0.67 |
ENST00000326505.3
|
B3GNT5
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
chr8_-_120651020 | 0.66 |
ENST00000522826.1
ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr14_+_33408449 | 0.66 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
chr11_-_82782861 | 0.65 |
ENST00000524635.1
ENST00000526205.1 ENST00000527633.1 ENST00000533486.1 ENST00000533276.2 |
RAB30
|
RAB30, member RAS oncogene family |
chr13_-_103451307 | 0.64 |
ENST00000376004.4
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1 |
chr6_+_39760783 | 0.63 |
ENST00000398904.2
ENST00000538976.1 |
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
chr14_-_53417732 | 0.63 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
chr17_+_53342311 | 0.61 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr6_-_88876058 | 0.61 |
ENST00000369501.2
|
CNR1
|
cannabinoid receptor 1 (brain) |
chr10_-_100027943 | 0.61 |
ENST00000260702.3
|
LOXL4
|
lysyl oxidase-like 4 |
chr10_+_52751010 | 0.61 |
ENST00000373985.1
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
chr6_+_143929307 | 0.61 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr5_+_153418466 | 0.60 |
ENST00000522782.1
ENST00000439768.2 ENST00000436816.1 ENST00000322602.5 ENST00000522177.1 ENST00000520899.1 |
MFAP3
|
microfibrillar-associated protein 3 |
chr12_-_69326940 | 0.59 |
ENST00000549781.1
ENST00000548262.1 ENST00000551568.1 ENST00000548954.1 |
CPM
|
carboxypeptidase M |
chr12_+_2162447 | 0.57 |
ENST00000335762.5
ENST00000399655.1 |
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr9_+_112403088 | 0.56 |
ENST00000448454.2
|
PALM2
|
paralemmin 2 |
chr3_+_158288942 | 0.56 |
ENST00000491767.1
ENST00000355893.5 |
MLF1
|
myeloid leukemia factor 1 |
chr2_-_164592497 | 0.55 |
ENST00000333129.3
ENST00000409634.1 |
FIGN
|
fidgetin |
chr12_+_122516626 | 0.54 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr17_-_41623716 | 0.54 |
ENST00000319349.5
|
ETV4
|
ets variant 4 |
chr5_-_139726181 | 0.53 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr4_-_16077741 | 0.53 |
ENST00000447510.2
ENST00000540805.1 ENST00000539194.1 |
PROM1
|
prominin 1 |
chr14_-_35182994 | 0.53 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
chr1_+_213123915 | 0.52 |
ENST00000366968.4
ENST00000490792.1 |
VASH2
|
vasohibin 2 |
chr1_-_165325939 | 0.51 |
ENST00000342310.3
|
LMX1A
|
LIM homeobox transcription factor 1, alpha |
chr14_-_31495569 | 0.51 |
ENST00000357479.5
ENST00000355683.5 |
STRN3
|
striatin, calmodulin binding protein 3 |
chr2_-_162931052 | 0.51 |
ENST00000360534.3
|
DPP4
|
dipeptidyl-peptidase 4 |
chr11_+_35965531 | 0.51 |
ENST00000528989.1
ENST00000524419.1 ENST00000315571.5 |
LDLRAD3
|
low density lipoprotein receptor class A domain containing 3 |
chr8_-_70747205 | 0.49 |
ENST00000260126.4
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1 |
chrX_+_115567767 | 0.49 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chrX_+_24167746 | 0.49 |
ENST00000428571.1
ENST00000539115.1 |
ZFX
|
zinc finger protein, X-linked |
chr3_-_190040223 | 0.48 |
ENST00000295522.3
|
CLDN1
|
claudin 1 |
chr20_-_25604811 | 0.48 |
ENST00000304788.3
|
NANP
|
N-acetylneuraminic acid phosphatase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.0 | 7.9 | GO:0044691 | tooth eruption(GO:0044691) |
1.2 | 5.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 2.9 | GO:0018277 | protein deamination(GO:0018277) |
0.7 | 5.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 2.1 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.7 | 2.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.6 | 5.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.6 | 2.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.6 | 5.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 1.7 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.5 | 0.5 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.5 | 1.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.5 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 3.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 4.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 2.5 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.4 | 5.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 3.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 2.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.4 | 1.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 1.1 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.4 | 1.8 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.4 | 1.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.3 | 1.7 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 3.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.9 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.3 | 2.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 2.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 4.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.5 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.3 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 2.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 0.7 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 4.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 2.5 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 2.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 2.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.7 | GO:1905064 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.2 | 16.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.5 | GO:1903348 | cellular response to lead ion(GO:0071284) positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 1.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 1.0 | GO:2000302 | regulation of synaptic vesicle priming(GO:0010807) presynaptic dense core granule exocytosis(GO:0099525) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 3.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 2.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.4 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.1 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.4 | GO:0035261 | external genitalia morphogenesis(GO:0035261) canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.1 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.5 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 2.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 2.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.5 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 3.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 1.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 2.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 1.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 1.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.2 | GO:0100009 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.1 | 0.2 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 1.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.6 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.1 | GO:0060661 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.2 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.1 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.4 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 0.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 1.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.1 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.0 | 1.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 2.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.0 | 1.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.2 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.0 | 1.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.9 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.1 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.0 | 1.4 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 4.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.5 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 0.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 2.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.0 | 0.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 1.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 1.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.0 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.0 | 1.7 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 0.1 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 2.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.1 | GO:0090289 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) regulation of osteoclast proliferation(GO:0090289) negative regulation of osteoclast proliferation(GO:0090291) |
0.0 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.8 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.4 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 1.8 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 2.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:1900276 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 1.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 1.4 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.0 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 1.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 1.6 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.8 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 1.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
2.9 | 8.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 9.6 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.8 | 3.0 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.7 | 6.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 2.5 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-11 complex(GO:0043260) |
0.3 | 2.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 4.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 1.0 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 2.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 5.9 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 2.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.8 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.0 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 0.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.1 | 12.2 | GO:0005901 | caveola(GO:0005901) |
0.1 | 2.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.2 | GO:0043614 | multi-eIF complex(GO:0043614) translation preinitiation complex(GO:0070993) glial limiting end-foot(GO:0097451) |
0.1 | 2.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 3.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 33.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.0 | 3.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 2.4 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 1.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 2.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 2.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.0 | 2.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 7.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.7 | GO:0043679 | axon terminus(GO:0043679) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 23.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.9 | 3.8 | GO:0017129 | triglyceride binding(GO:0017129) |
0.7 | 3.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.7 | 2.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.6 | 5.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 3.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.4 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 3.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) ER retention sequence binding(GO:0046923) |
0.4 | 1.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 3.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 2.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.9 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 3.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 1.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 3.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 17.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.4 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.1 | 0.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 1.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 18.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 2.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 3.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.0 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 2.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.0 | 6.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0034191 | GBD domain binding(GO:0032427) apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 5.5 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 3.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 1.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 2.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 2.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 3.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 2.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.5 | GO:0042805 | actinin binding(GO:0042805) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 40.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 9.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 8.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 5.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 23.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 4.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 4.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 11.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 2.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 0.8 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.4 | 34.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 3.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 4.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 3.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 3.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 7.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 3.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |